Literature DB >> 32165256

Crosstalk between the mTOR and Nrf2/ARE signaling pathways as a target in the improvement of long-term potentiation.

Artem P Gureev1, Vasily N Popov2, Anatoly A Starkov3.   

Abstract

In recent years, a significant progress was made in understanding molecular mechanisms of long-term memory. Long-term memory formation requires strengthening of neuronal connections (LTP, long-term potentiation) associated with structural rearrangement of neurons. The key role in the synthesis of proteins essential for these rearrangements belong to mTOR (mammalian target of rapamycin) complexes and signaling pathways involved in mTOR regulation. Suppression of mTOR activity may impair synaptic plasticity and long-term memory, while mTOR activation inhibits autophagy, thereby potentiating amyloidosis and development of Alzheimer's disease (AD) accompanied by irreversible memory loss. Because of this, suppression/inhibition of mTOR might have unpredictable consequences on memory. The Nrf2/ARE signaling pathway affects almost all mitochondrial processes. The activation of this pathway improves memory and exhibits therapeutic effect in AD. In this review, we discuss the crosstalk between the Nrf2/ARE signaling and mTOR in the maintenance of synaptic plasticity. Nrf2 pathway can be activated by pharmacological agents and by changes in mitochondria functioning accompanying various neuronal dysfunctions.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; Long term memory; Neurons; Nrf2; mTOR

Mesh:

Substances:

Year:  2020        PMID: 32165256      PMCID: PMC7145749          DOI: 10.1016/j.expneurol.2020.113285

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  128 in total

1.  Direct control of mitochondrial function by mTOR.

Authors:  Arvind Ramanathan; Stuart L Schreiber
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-22       Impact factor: 11.205

2.  Nrf2 Transcription Factor Can Directly Regulate mTOR: LINKING CYTOPROTECTIVE GENE EXPRESSION TO A MAJOR METABOLIC REGULATOR THAT GENERATES REDOX ACTIVITY.

Authors:  Gabriel Bendavit; Tahar Aboulkassim; Khalid Hilmi; Sujay Shah; Gerald Batist
Journal:  J Biol Chem       Date:  2016-10-26       Impact factor: 5.157

3.  Polyphenols activate Nrf2 in astrocytes via H2O2, semiquinones, and quinones.

Authors:  Hilla Erlank; Anat Elmann; Ron Kohen; Joseph Kanner
Journal:  Free Radic Biol Med       Date:  2011-10-12       Impact factor: 7.376

4.  Tti1 and Tel2 are critical factors in mammalian target of rapamycin complex assembly.

Authors:  Takeshi Kaizuka; Taichi Hara; Noriko Oshiro; Ushio Kikkawa; Kazuyoshi Yonezawa; Kenji Takehana; Shun-Ichiro Iemura; Tohru Natsume; Noboru Mizushima
Journal:  J Biol Chem       Date:  2010-04-28       Impact factor: 5.157

5.  Activity-dependent neuroprotective protein (ADNP)-derived peptide (NAP) ameliorates hypobaric hypoxia induced oxidative stress in rat brain.

Authors:  Narendra K Sharma; Niroj K Sethy; Ram Niwas Meena; Govindsamy Ilavazhagan; Mainak Das; Kalpana Bhargava
Journal:  Peptides       Date:  2011-03-29       Impact factor: 3.750

6.  Inhibition of mTOR by rapamycin abolishes cognitive deficits and reduces amyloid-beta levels in a mouse model of Alzheimer's disease.

Authors:  Patricia Spilman; Natalia Podlutskaya; Matthew J Hart; Jayanta Debnath; Olivia Gorostiza; Dale Bredesen; Arlan Richardson; Randy Strong; Veronica Galvan
Journal:  PLoS One       Date:  2010-04-01       Impact factor: 3.240

7.  Neuronal activity regulates astrocytic Nrf2 signaling.

Authors:  Agata Habas; Junghyun Hahn; Xianhong Wang; Marta Margeta
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-21       Impact factor: 11.205

Review 8.  Neurocognitive Architecture of Working Memory.

Authors:  Johan Eriksson; Edward K Vogel; Anders Lansner; Fredrik Bergström; Lars Nyberg
Journal:  Neuron       Date:  2015-10-07       Impact factor: 17.173

9.  Hrd1 suppresses Nrf2-mediated cellular protection during liver cirrhosis.

Authors:  Tongde Wu; Fei Zhao; Beixue Gao; Can Tan; Naoko Yagishita; Toshihiro Nakajima; Pak K Wong; Eli Chapman; Deyu Fang; Donna D Zhang
Journal:  Genes Dev       Date:  2014-03-17       Impact factor: 11.361

10.  Nrf2 Deficiency Exacerbates Obesity-Induced Oxidative Stress, Neurovascular Dysfunction, Blood-Brain Barrier Disruption, Neuroinflammation, Amyloidogenic Gene Expression, and Cognitive Decline in Mice, Mimicking the Aging Phenotype.

Authors:  Stefano Tarantini; M Noa Valcarcel-Ares; Andriy Yabluchanskiy; Zsuzsanna Tucsek; Peter Hertelendy; Tamas Kiss; Tripti Gautam; Xin A Zhang; William E Sonntag; Rafael de Cabo; Eszter Farkas; Michael H Elliott; Michael T Kinter; Ferenc Deak; Zoltan Ungvari; Anna Csiszar
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2018-06-14       Impact factor: 6.053

View more
  9 in total

Review 1.  Altered Metabolism in Alzheimer Disease Brain: Role of Oxidative Stress.

Authors:  Nicole G Rummel; D Allan Butterfield
Journal:  Antioxid Redox Signal       Date:  2021-12-21       Impact factor: 7.468

2.  The neuropeptide VIP potentiates intestinal innate type 2 and type 3 immunity in response to feeding.

Authors:  Maud Pascal; Alexander Kazakov; Gabriel Lepousez; Pierre-Marie Lledo; Christoph Wilhelm; Gérard Eberl; Grégoire Chevalier; Lola Dubrule; Julie Deyrat; Alice Dupin; Soham Saha; Ferdinand Jagot; Kurt Sailor; Sophie Dulauroy; Carine Moigneu; Yasmine Belkaid
Journal:  Mucosal Immunol       Date:  2022-05-02       Impact factor: 8.701

3.  Orcinol Glucoside Improves Senile Osteoporosis through Attenuating Oxidative Stress and Autophagy of Osteoclast via Activating Nrf2/Keap1 and mTOR Signaling Pathway.

Authors:  Wan Gong; Mengqin Liu; Qi Zhang; Quanlong Zhang; Yang Wang; Qiming Zhao; Lu Xiang; Chengjian Zheng; Qiaoyan Zhang; Luping Qin
Journal:  Oxid Med Cell Longev       Date:  2022-05-09       Impact factor: 7.310

Review 4.  Repositioning of Immunomodulators: A Ray of Hope for Alzheimer's Disease?

Authors:  Antonio Munafò; Chiara Burgaletto; Giulia Di Benedetto; Marco Di Mauro; Rosaria Di Mauro; Renato Bernardini; Giuseppina Cantarella
Journal:  Front Neurosci       Date:  2020-12-04       Impact factor: 4.677

5.  A Quantitative Proteomics Approach to Gain Insight into NRF2-KEAP1 Skeletal Muscle System and Its Cysteine Redox Regulation.

Authors:  Rafay Abu; Li Yu; Ashok Kumar; Lie Gao; Vikas Kumar
Journal:  Genes (Basel)       Date:  2021-10-21       Impact factor: 4.096

6.  Brain Protection by Methylene Blue and Its Derivative, Azur B, via Activation of the Nrf2/ARE Pathway in Cisplatin-Induced Cognitive Impairment.

Authors:  Ekaterina P Krutskikh; Daria V Potanina; Natalia A Samoylova; Mariya V Gryaznova; Irina S Sadovnikova; Artem P Gureev; Vasily N Popov
Journal:  Pharmaceuticals (Basel)       Date:  2022-06-30

Review 7.  The Interaction of mTOR and Nrf2 in Neurogenesis and Its Implication in Neurodegenerative Diseases.

Authors:  Linda Ines Zoungrana; Meredith Krause-Hauch; Hao Wang; Mohammad Kasim Fatmi; Lauryn Bates; Zehui Li; Parth Kulkarni; Di Ren; Ji Li
Journal:  Cells       Date:  2022-06-28       Impact factor: 7.666

Review 8.  Systemic Actions of SGLT2 Inhibition on Chronic mTOR Activation as a Shared Pathogenic Mechanism between Alzheimer's Disease and Diabetes.

Authors:  Gabriela Dumitrita Stanciu; Razvan Nicolae Rusu; Veronica Bild; Leontina Elena Filipiuc; Bogdan-Ionel Tamba; Daniela Carmen Ababei
Journal:  Biomedicines       Date:  2021-05-19

9.  The Relationship between the Level of Anterior Cingulate Cortex Metabolites, Brain-Periphery Redox Imbalance, and the Clinical State of Patients with Schizophrenia and Personality Disorders.

Authors:  Amira Bryll; Wirginia Krzyściak; Paulina Karcz; Natalia Śmierciak; Tamas Kozicz; Justyna Skrzypek; Marta Szwajca; Maciej Pilecki; Tadeusz J Popiela
Journal:  Biomolecules       Date:  2020-09-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.